Skip to main content
. 2017 Mar 1;13(9):2164–2178. doi: 10.1080/21645515.2016.1277845

Figure 1.

Figure 1.

Current standard of care therapy in advanced NSCLC and Melanoma Notes: The current standards of care systemic therapy for metastatic non-small cell lung carcinoma (NSCLC) and melanoma. EGFR = epidermal growth factor receptor; ALK = anaplastic lymphoma kinase rearrangement; TKI = tyrosine kinase inhibitor; PD-1 = programmed cell death protein-1.